PROS1 and COVID-19: Consistent with scRNAseq data, plasma Protein S levels were higher in COVID-19 patients who maintained lung functions (i.e., sustained PaO2/FiO2 > 200), suggesting a potential role in counterbalancing the severity of inflammation of SARS-CoV-2 infection.